Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Nico Derichs"'
Autor:
Silke van Koningsbruggen-Rietschel, Jane C. Davies, Tacjana Pressler, Rainald Fischer, Gordon MacGregor, Scott H. Donaldson, Knut Smerud, Nils Meland, Jann Mortensen, Marie Ø. Fosbøl, Damian G. Downey, Astrid H. Myrset, Hugo Flaten, Philip D. Rye, The following investigators and their teams (in alphabetical order) conducted this study., Mary Carroll, Jane Davies, Carsten Schwarz, Nico Derichs, Damian Downey, Olaf Eickmeier, Pal Leyell Finstad, Marie Øbro Fossbøl, Marita Gilljam, Lena Hjelte, Alan Knox, Susanne Nährig, Joachim Riethmüller, Felix C. Ringshausen, AS AlgiPharma, Laura Gow, Joy Conway, William Bennett
Publikováno v:
ERJ Open Research, Vol 6, Iss 4 (2020)
Background OligoG is a low molecular-weight alginate oligosaccharide that improves the viscoelastic properties of cystic fibrosis (CF) mucus and disrupts biofilms, thereby potentiating the activity of antimicrobial agents. The efficacy of inhaled Oli
Externí odkaz:
https://doaj.org/article/bf6a51f4c4a3405ebe8677a3a47a674d
Autor:
Nico Derichs
Publikováno v:
European Respiratory Review, Vol 22, Iss 127, Pp 58-65 (2013)
Cystic fibrosis (CF) is caused by genetic mutations that affect the cystic fibrosis transmembrane conductance regulator (CFTR) protein. These mutations can impact the synthesis and transfer of the CFTR protein to the apical membrane of epithelial cel
Externí odkaz:
https://doaj.org/article/03f812376f2d488ca1e6af654a08d6f6
Autor:
Jennifer L. Taylor-Cousar, Andreas Kaiser, François Vermeulen, Peter Sandner, Clare Saunders, Nico Derichs, Isabelle Fajac, Renee Jensen, Jane C. Davies, Steven M. Rowe, Anja Hoffmann, Damian G. Downey, Christine E. Bear, Karoline Droebner, Soundos Saleh, George M. Solomon, Felix Ratjen, Daniel B. Rosenbluth, Anne Malfroot, Elizabeth Tullis, Stefan Willmann, Dilip Nazareth
Publikováno v:
Rio-CF Study Group, Derichs, N, Taylor-Cousar, J L, Davies, J C, Fajac, I, Tullis, E, Nazareth, D, Downey, D G, Rosenbluth, D, Malfroot, A, Saunders, C, Jensen, R, Solomon, G M, Vermeulen, F, Kaiser, A, Willmann, S, Saleh, S, Droebner, K, Sandner, P, Bear, C E, Hoffmann, A, Ratjen, F & Rowe, S M 2021, ' Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis ', Journal of Cystic Fibrosis, vol. 20, no. 6, pp. 1018-1025 . https://doi.org/10.1016/j.jcf.2021.07.015
BACKGROUND: Riociguat is a first-in-class soluble guanylate cyclase stimulator for which preclinical data suggested improvements in cystic fibrosis transmembrane conductance regulator (CFTR) function. METHODS: This international, multicenter, two-par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a372e9b8ce7beb6e7e0a0ae4c60ecd2f
https://pure.qub.ac.uk/en/publications/0aba0b21-9b6d-4143-a70d-193cd26ffef8
https://pure.qub.ac.uk/en/publications/0aba0b21-9b6d-4143-a70d-193cd26ffef8
Autor:
Herman de Kock, D. Kanters, Florence Namour, Katja Conrath, Olivier Van de Steen, Pavel Drevinek, Edward F. McKone, Nico Derichs, Jane C. Davies, Silke van Koningsbruggen-Rietschel, Lisa Allamassey
Publikováno v:
Journal of Cystic Fibrosis. 18:693-699
Background Investigation of novel cystic fibrosis transmembrane conductance regulator (CFTR) potentiators, such as GLPG1837, for CF patients with gating mutations is challenging as trials require patients to withhold ivacaftor, the current standard o
Autor:
Folke Brinkmann, Kathrin Jansen, Alexander Bollenbach, Anjona Schmidt-Choudhury, Dimitrios Tsikas, Kristine Chobanyan-Jürgens, Anna Wiemers, Beatrice Hanusch, Sebene Mayorandan, Manfred Ballmann, Thomas Lücke, Nico Derichs
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 3802, p 3802 (2020)
Journal of Clinical Medicine
Volume 9
Issue 12
Journal of Clinical Medicine
Volume 9
Issue 12
Alterations in the L-arginine (Arg)/nitric oxide (NO) pathway have been reported in cystic fibrosis (CF
OMIM 219700) as the result of various factors including systemic and local inflammatory activity in the airways. The aim of the present study
OMIM 219700) as the result of various factors including systemic and local inflammatory activity in the airways. The aim of the present study
Autor:
Kris De Boeck, Bente L. Aalbers, Nicholas J. Simmonds, Yasmin Yaakov, Elke De Wachter, Paola Melotti, Burkhart Tümmler, Inez Bronsveld, Nico Derichs, Michael Wilschanski, Teresinha Leal
Background 5T polymorphism is a CFTR mutation with unclear clinical consequences: the phenotype varies from healthy individuals to Cystic Fibrosis (CF). The aim of this study was to evaluate if nasal potential difference (NPD) and sweat testing corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d0afed9f9432e0ce7c1f69966cf1431
https://doi.org/10.1016/j.jcf.2019.07.001
https://doi.org/10.1016/j.jcf.2019.07.001
Autor:
Anjona Schmidt-Choudhury, Folke Brinkmann, Manfred Ballmann, Kathrin Jansen, Alexander Bollenbach, Kristine Chobanyan-Jürgens, Nico Derichs, T. Lücke, Sebene Mayorandan, Dimitrios Tsikas, Beatrice Hanusch
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 2012, p 2012 (2020)
Volume 9
Issue 6
Journal of Clinical Medicine, Vol 9, Iss 2012, p 2012 (2020)
Volume 9
Issue 6
Cystic fibrosis (CF
OMIM 219700) is a rare genetic disorder caused by a chloride channel defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L-arginine (Arg)/nitric oxide (NO) metabolism has been observed in C
OMIM 219700) is a rare genetic disorder caused by a chloride channel defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L-arginine (Arg)/nitric oxide (NO) metabolism has been observed in C
Autor:
Bruce C. Marshall, Kevin W Southern, Susanna A. McColley, Nico Derichs, Frank J. Accurso, Michael J. Rock, Patrick R. Sosnay, Philip M. Farrell, Michelle S. Howenstine, Terry B. White, Margaret Rosenfeld, Sarah E. Hempstead, Clement L. Ren, Isabelle Sermet-Gaudelus
Publikováno v:
JOURNAL OF PEDIATRICS
Objective Cystic fibrosis (CF), caused by mutations in the CF transmembrane conductance regulator ( CFTR ) gene, continues to present diagnostic challenges. Newborn screening and an evolving understanding of CF genetics have prompted a reconsideratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ab71ce30ef18d52007719f303c7b321
Objective Because cystic fibrosis (CF) can be difficult to diagnose, and because information about the genetic complexities and pathologic basis of the disease has grown so rapidly over the decades, several consensus conferences have been held by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6df23dc573248db86c52be7f3e5d37b
http://hdl.handle.net/11562/981404
http://hdl.handle.net/11562/981404
Autor:
Nico Derichs, Mitch Drumm, Margarida D. Amaral, Kris De Boeck, Jeffrey M. Beekman, Anil Mehta, Isabelle Sermet-Gaudelus, Ulrich Martin, Tanja Gonska, Marcus A. Mall
Publikováno v:
Journal of Cystic Fibrosis. 13(4):363-372